Increasing the amount of SUMO, a small protein in the brain, could be a way of treating diseases such as epilepsy and schizophrenia, reveal scientists at the University of Bristol, UK. Their findings are published online today in Nature.
Boys with Duchenne muscular dystrophy were able to walk on their own for a longer period of time and reduce their risk of scoliosis as a result of receiving daily steroid treatments for several years, according to a study published in the May 8, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
After screening hundreds of compounds for their effects on fat development, researchers have discovered that an ingredient found in some plants fights diabetes in mice without some of the side effects attributed to other antidiabetes drugs.
Virginia Bioinformatics Institute and Virginia Tech biological sciences associate professor Chris Lawrence is teaming up with Mayo Clinic on a $2.4 million project funded by the National Institute of Allergy and Infectious Diseases (NIAID). The work could help researchers develop treatments, diagnostic tools, and preventative measures for patients suffering from chronic rhinosinusitis (CRS).
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
Unlike many traditional alcohol and drug dependence treatment programs, mainstream smoking cessation programs generally exclude spiritual practice and beliefs from the treatment process. But a study by Oregon Health & Science University Smoking Cessation Center researchers reveals many smokers are receptive to and may benefit from their own spiritual resources, when attempting to quit.
Implanted pumps improved heart function enough in a small percentage of patients awaiting a heart transplant that they were able to leave the hospital without a pump and without a new heart, according to a study in Circulation: Journal of the American Heart Association.
A written constitution for the NHS, overseen by an independent Board of Governors are two of the major recommendations published today by the British Medical Association (BMA) in its proposals for the future of the NHS in England.
Bayer plans to enter the market for wound-healing products. Bayer Innovation GmbH ? a subsidiary of Bayer AG ? has developed a leading-edge technology for the manufacture of bioresorbable wound dressings on the basis of silica gel fibers. A ceremony was held on May 4 in Leverkusen to mark the inauguration of a pilot plant which will manufacture the wound dressing in sufficient quantities to enable clinical trials to be carried out.
Bristol-Myers Squibb and the Hepatitis B Foundation announced the launch of the fourth annual “AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis B” program, a public education initiative taking place during National Hepatitis B Awareness Week (May 7-11).